Clinical Trials on 复发性原发性腹膜癌 in Korea, Democratic People's Republic of
总计505个结果
-
Yonsei UniversityCanariaBio Inc.招聘中PARP 抑制剂耐药的卵巢癌、输卵管癌或原发性腹膜癌患者不适合铂类再治疗大韩民国
-
Korean Gynecologic Oncology Group未知
-
Seoul National University HospitalBoryung Pharmaceutical Co., Ltd主动,不招人
-
Yonsei University撤销
-
Yonsei University招聘中
-
Seoul National University Hospital招聘中
-
Seoul National University HospitalRF medical招聘中
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean Gynecologic Oncology... 和其他合作者招聘中
-
Ajou University School of Medicine完全的
-
Seoul National University HospitalBayer; Korean Society of Breast Imaging & Korean Society For Breast Screening未知
-
Yonsei UniversityTakeda招聘中既往接受过 PARP 抑制剂治疗的铂敏感复发性卵巢癌患者大韩民国
-
Seoul National University Bundang HospitalBoryung Pharmaceutical Co., Ltd; B. Braun Korea Co., Ltd.完全的
-
Gangnam Severance Hospital完全的
-
The Catholic University of KoreaKorean Cancer Study Group完全的
-
CellabMEDYooyoung Pharmaceutical Co., Ltd.完全的
-
Asan Medical Center招聘中
-
Seoul National University Hospital未知
-
Seoul National University Hospital未知
-
Seoul National University HospitalPharos iBio Co., Ltd.招聘中
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Severance Hospital招聘中乳腺癌 | 手术 | 复发性乳腺癌 | 雌激素受体阳性肿瘤 | 立体定向放疗 | Her2-negative Tumor大韩民国
-
Asan Medical CenterHoffmann-La Roche完全的
-
Kyungpook National University HospitalMinistry of Health & Welfare, Korea; Fresenius Medical Care Korea完全的
-
Chonnam National University HospitalRoche Pharma AG完全的